MYUNGMOON Pharm co.,Ltd (KRX:017180)
1,764.00
-18.00 (-1.01%)
At close: Nov 21, 2025
MYUNGMOON Pharm co.,Ltd Market Cap
MYUNGMOON Pharm co.,Ltd has a market cap or net worth of 57.43 billion as of November 26, 2025. Its market cap has decreased by -25.69% in one year.
Market Cap
57.43B
Enterprise Value
152.87B
Revenue
193.64B
Ranking
n/a
PE Ratio
40.26
Stock Price
1,764.00
Market Cap Chart
Since July 10, 2008, MYUNGMOON Pharm co.,Ltd's market cap has increased from 35.32B to 57.43B, an increase of 62.62%. That is a compound annual growth rate of 2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 57.43B | -5.55% |
| Dec 30, 2024 | 60.81B | -20.64% |
| Dec 28, 2023 | 76.62B | -21.03% |
| Dec 29, 2022 | 97.02B | -39.32% |
| Dec 30, 2021 | 159.90B | -34.94% |
| Dec 30, 2020 | 245.77B | 106.68% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.32T |
| Celltrion | 39.84T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.05T |
| ABL Bio | 9.54T |
| Yuhan | 8.55T |
| Peptron | 7.30T |
| LigaChem Biosciences | 6.25T |